 |
 |
 |
||
|
||||
 |
|
| Updated Sep. 1, 2010 |
|
||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
||||||||
| |
|
Contemporary Management of Clostridium difficile - Associated Disease
ISSUE: SEPTEMBER, 2007 Clostridium difficile–associated disease (CDAD) is a primarily nosocomial diarrheal illness that is increasing in incidence and severity, partly because of the recently recognized hypervirulent NAP1 epidemic strain. read more | |
|
Managing Methicillin-Resistant Staphylococcus aureus 2006
ISSUE: SEPTEMBER, 2006 Staphylococcus aureus (S. aureus) is one of the most formidable infectious bacteria currently challenging clinicians. Historically, vancomycin was the mainstay of treatment for methicillin-resistant S. aureus (MRSA)infections. read more | |
|
Commentary: The Future of Parenteral Antibiotics
ISSUE: SEPTEMBER, 2005 With strains of methicillin-resistant staphylococci and resistant gramnegative bacteria on the rise, the use of parenteral antibiotics should be increasing significantly. read more |
| |
| MOREBACTERIAL INFECTIONS/MRSA | |
| |
| No more articles availalble | |
 Bacterial Infections/MRSA Archives |
| home | about us | advertise | contact | publications |